← Back to headlines
AbbVie Gains Approval for Decnupaz Drug
AbbVie has received approval for its new drug, Decnupaz, intended for the treatment of a rare hematologic malignancy.
27 May, 19:55 — 27 May, 19:55
Sources
Showing 1 of 1 sources
Related Stories
Asian Markets Fall and Oil Prices Rise Amid Escalating US-Iran Tensions
52m ago
US Treasury Secretary Urges Bank of Japan to Maintain Sound Monetary Policy Amid Yen Volatility
1h ago
BOJ to debate rate rise, inflation much closer to 2% target: governor
1h ago
Apple Names John Ternus as New CEO With Multi-Million Dollar Compensation Package
2h ago